SCHEMBL9893629

SCHEMBL9893629

CCC(C)(C)OC(=O)N1CCC(O)C1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.43
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
HPGD P15428 1/20 0.38
DPP7 Q9UHL4 2/20 0.37
RECQL P46063 1/20 0.36
EPHX1 P07099 1/20 0.36
USP30 Q70CQ3 1/20 0.36
NR1H2 P55055 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
GAA P10253 1/20 0.35
GPR119 Q8TDV5 2/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24175984 1.00 DPP4 (0.43) DPP4MEN1ALDH1A1MAPTKMT2A
SCHEMBL470938 0.90 HPGD (0.43) DPP4MAPTHPGDRECQLEPHX1
SCHEMBL21893357 0.88 DPP4 (0.41) DPP4MEN1ALDH1A1MAPTKMT2A
SCHEMBL21892739 0.86 NR1H2 (0.42) DPP4MEN1ALDH1A1MAPTKMT2A
SCHEMBL22278075 0.85 DPP4 (0.40) DPP4MEN1ALDH1A1MAPTKMT2A
SCHEMBL10723447 0.83 DPP7 (0.43) DPP4MEN1ALDH1A1MAPTKMT2A
SCHEMBL14431 0.83 HPGD (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL14494 0.83 HPGD (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL241055 0.83 HPGD (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL24116576 0.83 DPP4 (0.38) DPP4MEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382913-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF ORGANOVO, INC. 2023-11-30 US disclosed
WO-2022064863-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMATION METHOD JSR株式会社 2022-03-31 WO disclosed
US-8697335-B2 Radiation-sensitive resin composition and compound JSR CORPORATION (JP) 2014-04-15 US disclosed
US-20120148952-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND COMPOUND JSR CORPORATION (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120148952-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND COMPOUND RAD1, RER1, RPA1 DPP4 4719/4885MEN1 3098/4885ALDH1A1 806/4885
US-20230382913-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF NR1H4, NR1H2, NR1H3 DPP4 954/4885MEN1 2725/4885ALDH1A1 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.